Source-linked AI summary
ARMR: Adaptively Responsive Network for Medication Recommendation
Feiyue Wu, Tianxing Wu, Shenqi Jing
TL;DR
Medication recommendation for patients with complex conditions must balance reuse of historical medications with introducing new drugs as health conditions change. ARMR combines piecewise temporal learning of recent and distant history with adaptive attention to new and existing drugs. On MIMIC-III and MIMIC-IV, it outperforms state-of-the-art baselines, with reported gains in Jaccard similarity and PRAUC.
Problem
Existing methods can struggle to balance reuse of historical medications with introducing new drugs as patient conditions change, especially in medication recommendation for complex conditions.
Source: §1 · p. 1Method
ARMR combines piecewise temporal learning of long- and short-term records with adaptive adjustment of attention to new and existing drugs using current health condition and medication history.
Source: §1 · p. 2Results
ARMR outperforms state-of-the-art baselines by 2.16% in Jaccard similarity and 2.55% in PRAUC on two public medical datasets.
Source: §1 · p. 2Takeaways & Limitations
ARMR offers a medication-recommendation approach that jointly accounts for changing patient conditions, temporal history, and new versus existing medications.
Source: §1 · p. 2, §6 · p. 7Quantitative evaluation of correct new-drug introduction and improved explainability are left for future work.
Source: §6 · p. 7
Abstract
from arXiv · showhide
Medication recommendation is a crucial task in healthcare, especially for patients with complex medical conditions. However, existing methods often struggle to effectively balance the reuse of historical medications with the introduction of new drugs in response to the changing patient conditions. In order to address this challenge, we propose an Adaptively Responsive network for Medication Recommendation (ARMR), a new method which incorporates 1) a piecewise temporal learning component that distinguishes between recent and distant patient history, enabling more nuanced temporal understanding, and 2) an adaptively responsive mechanism that dynamically adjusts attention to new and existing drugs based on the patient's current health state and medication history. Experiments on the MIMIC-III and MIMIC-IV datasets indicate that ARMR has better performance compared with the state-of-the-art baselines in different evaluation metrics, which contributes to more personalized and accurate medication recommendations. The source code is publicly avaiable at: https://github.com/seucoin/armr2.
1 Introduction
Medication recommendation is difficult for patients with complex conditions because methods may underemphasize new drugs and distant history. ARMR combines piecewise temporal learning with adaptive attention to new and existing drugs, and is reported to outperform state-of-the-art baselines on two public datasets.
1 Introduction
- Medication recommendation personalizes medication plans using medical history, current diagnoses, and other relevant patient information, with added difficulty for complex conditions.Complex histories and variable medication responses make the task challenging.Source: §1 · p. 1
- New drugs account for about 30% of drugs in prescribed sets on average, while many methods prioritize reuse of old drugs or recommend full medication sets.The introduction identifies this as a gap in modeling new-drug patterns.Source: §1 · p. 1
- Longer intervals between admissions generally correspond to greater differences between medical code sets, yet many methods focus primarily on recent data.The introduction notes that distant records can still be crucial for understanding a patient's current condition.Source: §1 · p. 2, Figure 2 · p. 2
- ARMR combines piecewise temporal learning with adaptive attention to new and existing drugs based on current health condition and medication history.PTL distinguishes long-term from short-term records; the adaptive mechanism adjusts attention to new and old drugs.Source: §1 · p. 2
- In comprehensive experiments on two public medical datasets, ARMR outperforms the state-of-the-art baselines, achieving improvements of 2.16% in Jaccard similarity and 2.55% in PRAUC, respectively.Source: §1 · p. 2
2 Related Work
Prior medication-recommendation work includes rule-based, instance-based, and longitudinal approaches. ARMR distinguishes itself by separating new from historical medications and using fine-grained temporal learning to capture evolving patient conditions.
2 Related Work
- Medication-recommendation methods are grouped into rule-based, instance-based, and longitudinal categories according to the information they use.Longitudinal approaches model sequential dependencies in treatment histories.Source: §2 · p. 2
- Rule-based methods use clinical guidelines or rules derived from records, but may require substantial clinician input and lack generalizability.Examples include mappings from patient characteristics to treatments and rules extracted from discharge summaries.Source: §2 · p. 2
- Instance-based methods use current-visit data, while longitudinal methods model treatment-history dependencies using approaches including RNNs, graphs, memory, and Transformers.The section also notes work exploring large language models for medication recommendation.Source: §2 · p. 2
- ARMR differentiates historical from new medications and incorporates fine-grained temporal learning to capture evolving patient conditions.The stated aim is more precise and personalized medication recommendations.Source: §2 · pp. 2–3
3 Preliminaries
The preliminaries represent an electronic health record as a sequence of patient visits, each described by diagnosis, procedure, and medication sets. Medication recommendation uses current diagnoses and procedures together with prior visits to recommend the current medication combination.
3 Preliminaries
- An electronic health record is a sequence of visits, each represented by diagnosis, procedure, and medication sets.The sequence length is the patient's total number of visits.Source: §3.1 · p. 3
- Medication recommendation takes current diagnoses and procedures plus historical visits as input and aims to recommend an appropriate medication combination for the current visit.Source: §3.1 · p. 3
- Table 1 is identified as the notation reference for ARMR.Source: Table 1 · p. 3
4 The Proposed Method
ARMR combines temporal patient-history encoding, responsive representations of existing and new medications, and patient representations to predict medication sets. Its recommendation and training stages turn these representations into thresholded drug predictions.
4.1 Overall Arcitecture
- ARMR combines piecewise temporal learning, an adaptively responsive module, patient representation learning, and joint recommendation to predict the last medication set.The architecture also uses Mamba within PTL as a sequence temporal extractor.Source: §4.1 · p. 3, Figure 3 · p. 4
4.2 Piecewise Temporal Learning
- PTL separates recent from distant records, models them with a feedforward network and Mamba, then attends to distant information using recent context before concatenating representations.The split point N is a hyperparameter; the feedforward network captures recent changes, while Mamba models distant changes and long-range dependencies.Source: §4.2 · p. 3
4.3 Adaptively Responsive Module
- The adaptively responsive module separates historical medications into existing and newly introduced drugs, applies distinct PTL components, and uses their time-sensitive representations to form dynamic medication embeddings.Used- and unused-drug masks explicitly distinguish medications in the history from potential new treatments.Source: §4.3 · pp. 4–5
4.4 Patient Representation Learning
- The patient representation module encodes diagnosis and procedure codes per visit, applies separate PTL components to both sequences, and combines their temporal representations.The resulting patient representation integrates diagnosis and procedure content with temporal information for subsequent recommendation.Source: §4.4 · p. 5
4.5 Joint Recommendation
- Joint recommendation combines a direct patient-to-drug prediction with cosine-similarity scores between the patient representation and responsive medication embeddings.Learned weights combine the outputs before sigmoid activation constrains values to [0, 1].Source: §4.5 · p. 5
4.6 Model Training and Inference
- Training treats each drug as a binary prediction and combines binary cross-entropy with multi-label hinge loss; inference thresholds output probabilities at δ = 0.5.The losses are combined using α = 0.7, and training aggregates loss across each patient's visits before backpropagation.Source: §4.6 · pp. 5–6
5 Experiments
Experiments on MIMIC-III and MIMIC-IV compare ARMR with medication-recommendation baselines and variants. ARMR outperforms the baselines overall, and the ablation and case-study results examine its components and medication recommendations.
5.1 Experimental Setting
- Experiments use 131 ATC Third Level medication labels from MIMIC-III and MIMIC-IV, comparing ARMR with traditional and deep-learning baselines.Evaluation averages Jaccard, F1, and PRAUC across patients.Source: §5.1 · p. 6
5.3 Ablation Study
- ARMR outperforms the no-PTL and no-ARM variants, while weaker PTL variants indicate the value of distinguishing recent from distant history.The authors also report that the Mamba-based ARMR w/o PTL(L) outperforms the standard-RNN ARMR w/o PTL, associating this with long-range dependency capture and computational efficiency.Source: §5.3 · pp. 6–7
5.2 Performance Comparison
- ARMR consistently outperforms all baselines on Jaccard, F1, and PRAUC across the reported evaluation; Table 3 compares methods on MIMIC-III and MIMIC-IV.The authors relate its performance to integrating historical data with current health dynamics.Source: §5.2 · p. 6, Table 3 · p. 7
5.4 Case Study
- In the five-visit case, ARMR predicts the most correct new drugs and more correct historical drugs while recommending relatively fewer unseen drugs.It shows comparable proficiency to COGNet for appropriate continued-use medications, while COGNet tends to recommend more unseen drugs.Source: Figure 4 · p. 7, §5.4 · p. 7
6 Conclusion
ARMR combines piecewise temporal learning with an adaptively responsive module for medication recommendation. Experiments on MIMIC-III and MIMIC-IV show that it outperforms existing baselines.
6 Conclusion
- ARMR uses piecewise temporal learning to extract changing patient conditions and an adaptively responsive module to determine how to use existing and new medications.The authors report that ARMR outperforms existing baselines on MIMIC-III and MIMIC-IV.Source: §6 · p. 7